Chronic Subdural Haematoma: Systematic Review Highlighting Risk Factors for Recurrent Bleeds
DOI:
https://doi.org/10.17140/NOJ-4-125Keywords:
Chronic subdural haematoma, Recurrence, Bur hole drainage, OutcomeAbstract
Introduction: Chronic subdural haematoma (CSDH) is one of the commonest forms of intracranial haemorrhage. Surgical drainage of CSDH is a routine operation in the modern neurosurgical practice which has shown to be the most effective way in treating this entity; however, the incidence of recurrence of the haematoma post operatively remains as high as 26.5%. The risk factors for CSDH recurrence remains an area of ongoing research.
Objective: We have conducted a systematic review to evaluate the available literature addressing the risk factors for CSDH recurrence, aiming to minimise or at least identify patients at higher risk of recurrence in order to decrease associated morbidity.
Methods: Ovid via Medline, PubMed, and Google scholar databases were searched for eligible studies, search results were then limited to studies in English language, Humans and studies published within the last 5 years. The included studies were critically appraised using the Critical Appraisal Skills Programme (CASP) tool, and each study has then been ranked using the Harbour and Miller hierarchy of ranking.
Results: Based on available evidence, we classified the risk factors associated with recurrence to patients’, radiological, and surgical factors. Patient factors include history of seizures, trauma, alcoholism, brain atrophy, and presence of CSF shunts, while the role of diabetes in relation to the recurrence is controversial. Radiologically the presence of air in the subdural space post-operatively, the width of the haematoma, and the presence of bilateral CSDHs are associated with increased risk of recurrence. While the predictive value of multiple membranes in the CSDH remains controversial. Surgically, the risk of recurrence was noted to be higher in patients with parietal or occipital compared to those who had frontal burr hole drainage, also placing a subdural drain decreases the chance of recurrence and some evidence showed better outcomes for frontally placed drains. The role of anti-inflammatory agents (including steroids) remains an area of ongoing debate.
Conclusions: Risk factors for CSDH can be divided into patients’, radiological, and surgical factors. We encourage health care providers to minimize if not prevent potentially avoidable factors. Patients with increased risks for recurrence should be identified early by the treating team and when possible should be informed about their higher than usual risk of recurrence. Moreover this review highlights the general lack of a sufficiently.
References
Asano Y, Hasuo M, Takahashi I, Shimosawa S. Recurrent cas-es of chronic subdural hematoma--its clinical review and serial CT findings. No to Shinkei. 1992; 44(9): 827-831.
El-Kadi H, Miele VJ, Kaufman HH. Prognosis of chronic sub-dural hematomas. Neurosurg Clin N Am. 2000; 11: 553-556.
Ducruet AF, Grobelny BT, Zacharia BE, et al. The surgical management of chronic subdural hematoma. Neurosurg Rev. 2012; 35: 155-169. doi: 10.1007/s10143-011-0349-y
Aspegren OP, Astrand R, Lundgren MI, Romner B. Antico-agulation therapy a risk factor for the development of chronic subdural hematoma. Clin Neurol Neurosurg. 2013; 115: 981- 984. doi: 10.1016/j.clineuro.2012.10.008
Nakaguchi H, Tanishima T, Yoshimasu N. Factors in the natu-ral history of chronic subdural hematomas that influence their postoperative recurrence. J Neurosurg. 2001; 95: 256-262.
Wakai S, Hashimoto K, Watanabe N, Inoh S, Ochiai C, Nagai M. Efficacy of closed-system drainage in treating chronic sub-dural hematoma: Aprospective comparative study. Neurosur-gery. 1990; 26: 771-773.
Zumkeller M, Höllerhage HG, Dietz H. Treatment outcome in patients with chronic subdural hematoma with reference to age and concurrent internal diseases [In German]. Wien Med Wochenschr. 1997; 147: 55-62.
Lewis S, Orland B. The importance and impact of evidence-based medicine. J Manag Care Pharm. 2004: 10(5 Suppl A): 3-5. doi: 10.18553/jmcp.2004.10.S5-A.S3
Critical Appraisal Skills Programme (CASP). 2010 Tools. [Online]. Web site. http://www.casp-uk.net/#!checklists/cb36. Accessed April 19, 2017.
Harbour R, Miller J. Education and debate: A new system for grading recommendation in evidence based guidelines. BMJ. 2001: 323: 334-336.
Egger M, Smith GD. Bias in location and selection of studies. BMJ. 1998; 316(7124): 61-66.
Nakaguchi H, Tanishima T, Yoshimasu N. Relationship be-tween drainage catheter location and postoperative recurrence of chronic subdural hematoma after burr-hole irrigation and closed-system drainage. J Neurosurg. 2000; 93(5): 791-795. doi: 10.3171/jns.2000.93.5.0791
Yamamoto H, Hirashima Y, Hamada H, Hayashi N, Origasa H, Endo S. Independent predictors of recurrence of chronic sub-dural hematoma: Results of multivariate analysis performed us-ing a logistic regression model. J Neurosurg. 2003; 98(6): 1217- 1221. doi: 10.3171/jns.2003.98.6.1217
Foelholm R, Waltimo O. Epidemiology of chronic subdural haematoma. Acta Neurochir. 1975; 32: 247-250. doi: 10.1007/ BF01405457
Fogelholm R, Heiskanen O, Waltimo O. Chronic subdural hematoma in adults. Influence of patient’s age on symptoms, signs, and thickness of hematoma. J Neurosurg. 1975; 42: 43- 46. doi: 10.3171/jns.1975.42.1.0043
Fukuhara T, Gotoh M, Asari S, et al. The relationship be-tween brain surface elastance and brain reexpansion after evacu-ation of chronic subdural hematoma. Surg Neurol. 1996; 45: 570-574. doi: 10.1016/0090-3019(95)00471-8
Torihashi K, Sadamasa N, Yoshida K, Narumi O, Chin M, Yamagata S. Independent predictors for recurrence of chronic subdural hematoma: A review of 343 consecutive surgical cas-es. Neurosurgery. 2008; 63(6): 1125-1129. doi: 10.1227/01. NEU.0000335782.60059.17
Probst C. Peritoneal drainage of chronic subdural hema-tomas in older patients. J Neurosurg. 1988; 68: 908-911. doi: 10.3171/jns.1988.68.6.0908
Robinson RG. Chronic subdural hematoma: Surgical man-agement in 133 patients. J Neurosurg. 1984; 61: 263-268. doi: 10.3171/jns.1984.61.2.0263
Abouzari M, Rashidi A, Rezaii J, et al. The role of postopera-tive patient posture in the recurrence of traumatic chronic subdu-ral hematoma after burr hole surgery. Neurosurgery 2007; 61(4): 794-797. doi: 10.1227/01.NEU.0000298908.94129.67
Frati A, Salvati M, Mainiero F, et al. Inflammation markers and risk factors for recurrence in 35 patients with a posttrau-matic chronic subdural hematoma: A prospective study. J Neu-rosurg. 2004. 100(1) 24-32. doi: 10.3171/jns.2004.100.1.0024
Qian Z, Yang D, Sun F, Sun Z. Risk factors for recurrence of chronic subdural hematoma after burr hole surgery: Potential protective role of dexamethasone. Br J Neurosurg. 2017; 31(1): 84-88. doi: 10.1080/02688697.2016.1260686
Nomura S, Kashiwagi S, Fujisawa H, et al. Characterization of local hyperfibrinolysis in chronic subdural hematomas by SD-SPAGE and immunoblot. J Neurosurg. 1994; 81: 910-913. doi: 10.3171/jns.1994.81.6.0910
Oishi M, Toyama M, Tamatani S, et al. Clinical factors of recurrent chronic subdural hematoma. Neurol Med Chir. 2001; 41: 382-386. doi: 10.2176/nmc.41.382
Park CK, Choi KH, Kim MC, et al. Spontaneous evolu-tion of posttraumatic subdural hygroma into chronic subdural haematoma. Acta Neurochir. 1994; 127: 41-47. doi: 10.1007/ BF01808545
So CC, Wong KF. Valproate-associated dysmyelopoiesis in elderly patients. Am J Clin Pathol. 2002; 118: 225-228. doi: 10.1309/4TEF-LVGX-WEQ9-R8W8
Foelholm R, Waltimo O. Epidemiology of chronic subdural haematoma. Acta Neurochir. 1975; 32: 247-250. doi: 10.1007/ BF01405457
Mori K, Maeda M. Surgical treatment of chronic subdural hematoma in 500 consecutive cases: Clinical characteristics, surgical outcome, complications, and recurrence rate. Neurol Med Chir (Tokyo). 2001; 41: 371-381. doi: 10.2176/nmc.41.371
Kernan WN, Inzucci SE, Viscoli CM, et al. Insulin resistance and risk for stroke. Neurology. 2002; 59: 809-815. doi: 10. 1212/ WNL.59. 6. 809
Suzuki J, Takaku A. Nonsurgical treatment of chronic subdu-ral hematoma. J Neurosurg. 1970; 33(5): 548-553. doi: 10.3171/ jns.1970.33.5.0548
Ito H, Komai T, Yamamoto S. Fibrinolytic enzyme in the lin-ing walls of chronic subdural hematoma. J Neurosurg. 1978; 48: 197-200. doi: 10.3171/jns.1978.48.2.0197
Tokmak M, Iplikcioglu AC, Bek S, Gökduman CA, Erdal M. The role of exudation in chronic subdural hematomas. J Neuro-surg. 2007; 107: 290-295. doi: 10.3171/JNS-07/08/0290
Tanikawa M, Mase M, Yamada K, et al. Surgical treatment of chronic subdural hematoma based on intrahematomal mem-brane structure on MRI. Acta Neurochir. 2001; 143: 613-619. doi: 10.1007/s007010170067
Nakajima H, Yasui T, Nishikawa M, Kishi H, Kan M. The role of postoperative patient posture in the recurrence of chronic subdural hematoma: A prospective randomized trial. Surg Neu-rol. 2002; 58: 385-387. doi: 10.1016/S0090-3019(02)00921-7
Markwalder TM. Chronic subdural hematomas: A review. J Neurosurg. 1981; 54: 637-645. doi: 10.3171/jns.1981.54.5.0637
Nagata K, Asano T, Basugi N, et al. Studies on the operative factors affecting the reduction of chronic subdural hematoma, with special reference to the residual air in the hematoma cavity. No Shinkei Geka. 1989;17: 15-20.
Smyth H, Livingston K. Ventricular infusion in the operative management of subdural hematoma. In: Morley T, ed. Current Controversies in Neurosurgery. Philadelphia, USA: WB Saun-ders; 1976: 566-571.
Santarius T, Kirkpatrick PJ, Ganesan D et al. Use of drains versus no drains after burr-hole evacuation of chronic subdural haematoma: A randomised controlled trial. The Lancet. 2009; 374(9695): 1067-1073. doi: 10.1016/S0140-6736(09)61115-6
Virchow R. Das Hamaton der dura mater [In German]. Verch Phys Med Ges Wurzburg. 1857; 7: 134-142
Markwalder TM, Steinsiepe KF, Rohner M, et al. The course of chronic subdural haematoma after burr-hole craniostomy and closed-system drainage. J Neurosurg. 1981; 55: 390-396. doi: 10.3171/jns.1981.55.3.0390
DEXamethasone in Chronic SubDural Haematoma (Dex-CSDH trial). A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic chronic subdural haematoma. Web site. http://www.dexcsdh.org/. Accessed Appril 02, 2017.
Brennan PM, Kolias AG, Joannides AJ, et al. The management and outcome for patients with chronic subdural hematoma: A prospective, multicenter, observational cohort study in the United Kingdom. J Neurosurg. 2017: 1-8. Ahead of print. doi: 10.3171/2016.8.JNS16134
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Neuro (NEURO) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.